Raymond James Financial Inc Madrigal Pharmaceuticals, Inc. Transaction History

Raymond James Financial Inc

  • $264 Billion
  • Q4 2024

A detailed history of Raymond James Financial Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 53,846 shares of MDGL stock, worth $17.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
53,846
Holding current value
$17.8 Million
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
BUY
$202.45 - $354.85 $10.9 Million - $19.1 Million
53,846 New
53,846 $16.6 Million

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.65B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Raymond James Financial Inc Portfolio

Follow Raymond James Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email